How Genomics Examines The Functioning Of Genes and Genetic Disorders?
The genomics
is defined as the study of a gene and its functioning. The concept of genomics
is aimed to understand the architecture of the genome which is comprised of the
deoxyribo nucleic acid (DNA), ribo nucleic acid (RNA) and proteins. Genomics is
meant to examine the molecular mechanisms and the interaction of genetic and
environmental factors in the diseases. The report would be of an interest to
various stakeholders operating in the genomics market. These stakeholders
include hospitals, research institutes, medical device suppliers, diagnostic
centers, academic institutes, market research, equipment manufacturers, and
consulting firms.
Key industry players operating in the field of genomics across the globe include Thermo Fisher Scientific Inc., Illumina Inc., and Eurofins. Other market players are Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Danaher, and GE Healthcare.
The nine trends that are contributing in shaping the genomics market include:
The nine trends that are contributing in shaping the genomics market include:
Adoption of NGS
Single-cell biology
Up-coming RNA biology
Up-coming molecular stethoscope
Genetic testing
Patients' diagnosis through genomics
Bioinformatics
Extensive research and clinical trials.
These trends have huge potentials to create
substantial commercial opportunities for in vitro diagnostic (IVD) companies.
Furthermore, key players such as Illumina, Qiagen, Thermo Fisher Scientific
Inc, Agilent, Roche and more are the key innovators for these technologies and
these are constantly engaged in the developments of products for the genomics.
![]() |
Genomics Market |

Comments
Post a Comment